Atara Biotherapeutics, Inc. (LON:0HIY)
9.49
+0.08 (0.85%)
At close: Jul 11, 2025
Atara Biotherapeutics Revenue
Atara Biotherapeutics had revenue of $98.15M USD in the quarter ending March 31, 2025, with 258.77% growth. This brings the company's revenue in the last twelve months to $199.73M, up 475.53% year-over-year. In the year 2024, Atara Biotherapeutics had annual revenue of $128.94M with 1,404.02% growth.
Revenue (ttm)
$199.73M
Revenue Growth
+475.53%
P/S Ratio
0.26
Revenue / Employee
$1.31M
Employees
153
Market Cap
40.76M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 128.94M | 120.37M | 1,404.02% |
Dec 31, 2023 | 8.57M | -55.00M | -86.51% |
Dec 31, 2022 | 63.57M | 43.23M | 212.55% |
Dec 31, 2021 | 20.34M | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Atara Biotherapeutics News
- 2 months ago - Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors - Business Wire
- 2 months ago - Atara Biotherapeutics GAAP EPS of $3.50, revenue of $98.15M - Seeking Alpha
- 2 months ago - Atara Biotherapeutics prices $16M public offering - Seeking Alpha
- 2 months ago - Atara Biotherapeutics Announces First Quarter Financial Results and Operational Progress - Business Wire
- 2 months ago - Atara Biotherapeutics Announces Pricing of $16 Million Offering - Business Wire
- 2 months ago - Atara Biotherapeutics to reduce workforce by 30% - Seeking Alpha
- 2 months ago - Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel) - Business Wire
- 4 months ago - Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress - Business Wire